SpyGlass Pharma, Inc.

SEC 4 · Filed

0001601264-26-000004Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 5, 2026

Grant, award or other acquisition by Dybbs Michael

Security
Stock Option (right to buy)
Code
A
Shares
27,400
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-05",
  "direction": "A",
  "exercise_price": "16",
  "expiration": "2036-02-05",
  "footnotes": {
    "F1": "Subject to the Reporting Person\u0027s continuing as an Outside Director (as defined in the Issuer\u0027s 2026 Equity Incentive Plan) through such applicable vesting date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Date of Grant on the same day of the month as the Date of Grant (and if there is no corresponding day, on the last day of the month). \"Date of Grant\" shall mean February 5, 2026."
  },
  "owners": [
    {
      "cik": "0001601264",
      "name": "Dybbs Michael",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "27400",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "27400",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "27400"
}